Atherosclerosis risk factors related to hemodialysis duration and erythropoietin therapy.

Dejanova, B

Atherosclerosis risk factors related to hemodialysis duration and erythropoietin therapy. [electronic resource] - Clinical chemistry and laboratory medicine Jun 2001 - 484-6 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1434-6621

10.1515/CCLM.2001.079 doi


Adult
Arteriosclerosis--etiology
Case-Control Studies
Erythropoietin--adverse effects
Female
Humans
Lipid Peroxidation--drug effects
Lipids--blood
Male
Middle Aged
Recombinant Proteins
Renal Dialysis--adverse effects
Risk Factors
Time Factors
Triglycerides--blood